INS and metabolic dysfunction-associated steatotic liver disease: In conclusion, while current evidence does not support the reversal of NAFLD by Bifidobacterium combinations, this meta-analysis suggests their potential in improving key metabolic and inflammatory markers, such as LDL, triglycerides, glucose, insulin, TNF-α, IL-6, and hs-CRP.